Opendata, web and dolomites

uCARE SIGNED

Understanding Circumventing Antibiotic REsistance

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 uCARE project word cloud

Explore the words cloud of the uCARE project. It provides you a very rough idea of what is the project "uCARE" about.

repertoire    uncover    implies    deadly    action    medication    mechanisms    hitherto    biological    gut    tens    basis    it    counteract    revisiting    ways    antibiotic    resistance    line    paths    map    seek    revert    combinations    cross    preliminary    reverse    drug    full    possibly    health    bacterial    again    chemical    genetics    250    throughput    reverting    delay    proof    imperative    living    yield    mode    once    bacteria    experimental    broad    microbes    prevent    driver    data    policies    profiling    systematically    underlying    severity    antidotes    drugs    public    identification    lived    equally    drivers    issue    antibacterial    undermining    candidates    antimicrobial    unnoticed    therapies    thermal    diseases    heels    indicate    elucidate    expose    networks    genetic    cellular    longer    principles    human    evolution    standards    utmost    achilles    fundamental    direct    spread    treatable    antibiotics    proteome    polypharmacy   

Project "uCARE" data sheet

The following table provides information about the project.

Coordinator
EUROPEAN MOLECULAR BIOLOGY LABORATORY 

Organization address
address: Meyerhofstrasse 1
city: HEIDELBERG
postcode: 69117
website: http://www.embl.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙986˙004 €
 EC max contribution 1˙986˙004 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-COG
 Funding Scheme ERC-COG
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2024-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EUROPEAN MOLECULAR BIOLOGY LABORATORY DE (HEIDELBERG) coordinator 1˙986˙004.00

Map

 Project objective

The evolution and spread of antibiotic resistance has become a public health concern of the utmost severity, making once treatable diseases deadly again and undermining our living standards. New therapies are imperative, but equally important are the understanding of the full repertoire of drivers of antibiotic resistance and the identification of ways to counteract them. We have recently established that ~250 non-antibiotic drugs have direct, strong and often broad antibacterial effects on human gut microbes. Moreover, preliminary data indicate that bacteria use similar general resistance mechanisms against both drugs with human targets and antibiotics. This implies that polypharmacy may be a hitherto unnoticed driver of antibiotic resistance. We will use chemical genetics and experimental evolution to systematically map the cross-resistance between human-targeted drugs and antibiotics, and elucidate underlying resistance mechanisms. Using these data, we will next seek to identify antidotes for the antimicrobial side-effects of non-antibiotic drugs, and exploit human-targeted drugs for reverting existing antibiotic resistance. At the genetic level, we will use high-throughput reverse genetics to expose the Achilles heels of bacterial cellular networks for resistance development. Finally, we will uncover the antimicrobial mode of action of tens of human-targeted drugs using thermal proteome profiling and chemical genetics. Together with the genetic information, this line of research will yield design principles and possibly new drug candidates for longer-lived, resistance-proof drug combinations. Overall, this project aims at improving our fundamental biological understanding of antibiotic resistance and the paths to prevent, delay or revert it. It can also set the basis for revisiting current medication policies. The derived principles are likely to be relevant to other diseases and therapies, in which resistance development is an issue.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UCARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "UCARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

HYDROGEN (2019)

HighlY performing proton exchange membrane water electrolysers with reinforceD membRanes fOr efficient hydrogen GENeration

Read More  

E-DIRECT (2020)

Evolution of Direct Reciprocity in Complex Environments

Read More  

REPLAY_DMN (2019)

A theory of global memory systems

Read More